| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099329 | Journal of Crohn's and Colitis | 2014 | 11 Pages |
Abstract
Infliximab and/or immunomodulators inhibit immune responses to some strains of trivalent influenza vaccination in adults with inflammatory bowel disease. For optimization of the trivalent influenza vaccination for patients with adult inflammatory bowel disease treated with immunosuppressive agents, establishing an effective vaccination method is crucial.
Keywords
CAICDAIAZAHAIIFX6-MercaptopurineGMT6MPNiSazathioprinestandard deviationImmunomodulatorInfliximabCrohn's diseaseInflammatory bowel diseaseWorld Health OrganizationCrohn's Disease Activity IndexClinical Activity Indexconfidence intervalhemagglutination inhibitionGeometric mean titerodds ratioinfluenza vaccineImmune responsesWHOUlcerative colitis
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Yoshie Hagihara, Satoko Ohfuji, Kenji Watanabe, Hirokazu Yamagami, Wakaba Fukushima, Kazuhiro Maeda, Noriko Kamata, Mitsue Sogawa, Masatsugu Shiba, Tetsuya Tanigawa, Kazunari Tominaga, Toshio Watanabe, Yasuhiro Fujiwara, Yoshio Hirota, Tetsuo Arakawa,